Metraipolis › archive › dc_e240e14e0eae
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42362555
- DOI
- 10.1038/s41523-[numero omesso]-y
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T08:34:46.478Z
- SHA-256 of the archived text
38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef- Stable URL of this page
https://metraipolis.com/documento/dc_e240e14e0eae
How to cite
Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555 — Europe PMC (en), https://europepmc.org/article/MED/42362555 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e240e14e0eae (Metraipolis archive dc_e240e14e0eae, sha256 38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef)
BibTeX
@misc{dce240e14e0eae,
title = {Prospective observational study of atezolizumab plus nab-paclitaxel in patients with metastatic triple-negative breast cancer: JBCRG-C08/ATTRIBUTE — Europe PMC PMID:42362555},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42362555},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e240e14e0eae; sha256 38ddb0989593516bcc34c5066ad32fd04707633196eea4d234a3377f46a294ef},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42362555. Agents can read the archived copy with the MCP tool read_document.